Keum Dong-Yoon, Kim Jae-Bum, Chae Min-Cheol
Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Korea.
Korean J Thorac Cardiovasc Surg. 2013 Jun;46(3):202-7. doi: 10.5090/kjtcs.2013.46.3.202. Epub 2013 Jun 5.
The role of totally implantable central venous port (TICVP) system is increasing. Implantation performed by radiologist with ultrasound-guided access of vein and fluoroscope-guided positioning of catheter is widely accepted nowadays. In this article, we summarized our experience of TICVP system by surgeon and present the success and complication rate of this surgical method.
Between March 2009 and December 2010, 245 ports were implanted in 242 patients by surgeon. These procedures were performed with one small skin incision and subcutaneous puncture of subclavian vein. Patient's profiles, indications of port system, early and delayed complications, and implanted period were evaluated.
There were 82 men and 160 women with mean age of 55.74. Port system was implanted on right chest in 203, and left chest in 42 patients. There was no intraoperative complication. Early complications occurred in 11 patients (4.49%) including malposition of catheter tip in 6, malfunction of catheter in 3, and port site infection in 2. Late complication occurred in 12 patients (4.90%).
Surgical insertion of TICVP system with percutaneous subclavian venous access is safe procedures with lower complications. Careful insertion of system and skilled management would decrease complication incidence.
全植入式中心静脉导管（TICVP）系统的作用日益增加。目前，由放射科医生在超声引导下进入静脉并在荧光镜引导下定位导管进行植入已被广泛接受。在本文中，我们总结了外科医生植入TICVP系统的经验，并介绍了这种手术方法的成功率和并发症发生率。
2009年3月至2010年12月期间，外科医生为242例患者植入了245个导管。这些手术通过一个小的皮肤切口和锁骨下静脉的皮下穿刺进行。对患者的资料、导管系统的适应证、早期和延迟并发症以及植入时间进行了评估。
男性82例，女性160例，平均年龄55.74岁。203例患者在右胸植入导管系统，42例在左胸植入。术中无并发症。11例患者（4.49%）出现早期并发症，包括导管尖端位置不当6例、导管故障3例、导管植入部位感染2例。12例患者（4.90%）出现晚期并发症。
经皮锁骨下静脉穿刺手术植入TICVP系统是安全的，并发症较少。仔细植入系统并进行熟练的管理可降低并发症发生率。
